TrialMolecular cancer research : MCR2014

ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.

Dara L Aisner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.